Alex Richter

Alex has been leading a team of experts from the University of Birmingham to develop a SARS-CoV-2 antibody test focussed on improving detection in individuals with mild COVID-19 disease. In collaboration with The Binding Site this is being commercialised. In collaboration with University Hospitals Birmingham NHS Foundation Trust and Birmingham Women’s and Children’s NHS Foundation Trust and Birmi...